new indications for glp-1 drugs GLP-1-based therapies diabetes, obesity and beyond How underwriters should interpret GLP-1

A drug screen, also called a toxicology panel, looks for evidence of controlled substance use

[DOI] [PMC free article] [PubMed] [Google Scholar] 14.Drucker DJ

Cost-effectiveness analyses of antihypertensive medicines: A systematic review

2024Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the surmount-4 randomized clinical trial

With Foundayo, we now have an oral option that delivered an average of 12.4% weight loss at the highest dose in clinical trials addressing both the clinical realities of obesity and the practical challenges patients face every day, Horn noted

Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacy